Errors about SBU statement and atenolol
Rehnqvist, N.
Lakartidningen 102(7): 503
2005
ISSN/ISBN: 0023-7205 PMID: 15768702 Document Number: 589114
Document emailed within 1 workday
Related Documents
Horby, P.W.; Laurie, K.L.; Cowling, B.J.; Engelhardt, O.G.; Sturm-Ramirez, K.; Sanchez, J.L.; Katz, J.M.; Uyeki, T.M.; Wood, J.; Van Kerkhove, M.D. 2017: CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement Influenza and other Respiratory Viruses 11(1): 2-14Edwards, K.G.; Tweed, J.A.; Saul, P.A.; Wright, F.W. 1986: A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension Pharmatherapeutica 4(10): 637-641
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Field, T.E. 1964: Common Errors Occurring in the Diagnosis of Testicular Neoplasms and the Effect of these Errors on Prognosis Journal of the Royal Army Medical Corps 110: 152-155
Markovits, P.; Contesso, G.; Bergiron, C.; Masselot, J.; Mouriesse 1972: Errors in the diagnosis of malignancy with mammography, apropos of 95 histologically verified errors Annales de Radiologie 15(11): 805-812
Ito, K. 1996: General tests--factors responsible for errors in sampling of urine, feces, cerebrospinal fluid, saliva, and other body fluids and prevention of these errors Rinsho Byori. Japanese Journal of Clinical Pathology Suppl. 103: 81-91
Mäkynen, P.; Karhumäki, L.; Seppänen, S. 1979: Atenolol once daily in angina Annals of Clinical Research 11(2): 53-57
Kulpati, D.D.; Kaushal, S.S.; Verma, N.; Raheja, S.M.; Raghu, A. 1984: Atenolol in the treatment of hypertension Indian Heart Journal 36(6): 379-383
Smith, N. 2001: Medical errors. Medical profession must take drug errors seriously Bmj 322(7299): 1424-1425
Gajewska, M.; Glass, G.; Kostelecki, J. 1992: Spectrofluorometric analysis of propranolol and atenolol Acta Poloniae Pharmaceutica 49(3): 1-4
Kale, P.A.; Soman, R.N. 1985: Atenolol as an anti-hypertensive drug Journal of Postgraduate Medicine 31(4): 187-191
Wolf, R.; Ophir, J.; Elman, M.; Krakowski, A. 1989: Atenolol-induced cutaneous vasculitis Cutis 43(3): 231-233
Coats, A.J.; Bird, R.J.; Conway, J. 1989: Predicting the blood pressure response to atenolol Journal of Human Hypertension 3(1): 65-66
Antalóczy, Z.; Kékes, E. 1992: Anti-anginal effect of Tenormin (atenolol) Therapia Hungarica 40(2): 58-63